Bone Biologics Corp Common Stock (BBLG) Stock Price

BBLGStock
$0.40−84.63%52W
Market Cap$1.09M
P/E—
PEG Ratio—
Div yield—
Beta0.86

BBLG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-78.56%
Price vs S&P 500 (4W)-15.64%
VGM Score11.06

BBLG Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$0.39-$0.43-10.26%(-$0.04)
Q1 2026-$0.54-$0.43+20.37%(+$0.11)
Q4 2025-$0.34-$0.63-85.29%(-$0.29)
Q3 2025-$1.23-$0.37+69.92%(+$0.86)
Q2 2025-$0.58-$1.33-129.31%(-$0.75)

BBLG Analyst Recommendations

Aug 2023
Sep 2023
Oct 2023
Nov 2023
4.14
4.14
4.14
4.14

Industry Peers — Orthopedic & Prosthetic Devices(31)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
BBLGBone Biologics Corp Common Stock
——F————$0.40
ISRGIntuitive Surgical Inc.DBB13.7x18.2%66.7%31.3%$426.70
EWEdwards Lifesciences CorpDCB7.7x6.7%77.8%18.2%$86.60
STESTERIS plcCCB3.6x13.8%44.4%18.9%$222.66
ZBHZimmer Biomet Holdings, Inc.BCB2.1x3.2%69.9%14.2%$94.98
SNNSmith & Nephew plcBCC1.9x6.2%68.2%12.9%$29.06
ALGNAlign Technology IncBDC2.5x10.3%69.0%13.2%$147.31
MSAMine Safety IncorporatedCCB3.5x6.8%47.6%21.2%$179.05
ESTAEstablishment Labs Holdings Inc.FAC7.2x20.0%70.5%-7.6%$59.18
ENOVEnovis CorporationBDC0.5x-6.0%61.4%-45.1%$19.59
CDRECadre Holdings, Inc.BCC1.6x8.6%41.8%10.1%$26.38

About Bone Biologics Corp Common Stock

Bone Biologics is a biotechnology company developing bone regeneration therapeutics. Its lead product, NELL-1, is a bone void filler designed for spinal, orthopedic, neurosurgery, and sports medicine procedures, with additional applications in plastic reconstruction and interventional radiology.